4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

CUSIP: 35104E100

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+1,439,888
Put/Call ratio
0%
SEC-reported price per share
$15.12
Number of holders
76
Value change
+$20,420,485
Number of buys
40
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,571,939

Security key

35104E100

Report period

Q1 2022

Institutions

76

Top holders

10

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 7.6% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 7.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 7.6%
BlackRock Finance, Inc. 4%
BVF INC/IL 3.9%
Deep Track Capital, LP 3.7%
Janus Henderson Group Ltd. 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F
Company
13F
7.6%
$86,398,000
3,937,914 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
4%
$45,803,000
2,087,682 shares
31 Dec 2021
BVF INC/IL
13F
Company
13F
3.9%
$44,009,000
2,005,862 shares
31 Dec 2021
Deep Track Capital, LP
13F
Company
13F
3.7%
$41,686,000
1,900,000 shares
31 Dec 2021
Janus Henderson Group Ltd.
13F
Company
13F
3.2%
$36,160,000
1,647,923 shares
31 Dec 2021
Octagon Capital Advisors LP
13F
Company
13F
3%
$34,030,000
1,551,070 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
76
Shares
26,134,053
Rows available
76
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
76
Q1 2022 holders
76
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .